Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Adhyatmika Adhyatmika"'
Autor:
Adhyatmika Adhyatmika, Kurnia S. S. Putri, Emilia Gore, Keri A. Mangnus, Catharina Reker-Smit, Detlef Schuppan, Leonie Beljaars, Peter Olinga, Barbro N. Melgert
Publikováno v:
Cellular Physiology and Biochemistry, Vol 56, Iss 1, Pp 28-38 (2022)
Externí odkaz:
https://doaj.org/article/e12d0fc7887a48bd8a9d137e079c8f9c
Autor:
Putri, Kurnia S. S., Adhyatmika, Adhyatmika, Boorsma, Carian E., Habibie, Habibie, Ruigrok, Mitchel J. R., Heukels, Peter, Timens, Wim, de Jager, Marina H., Hinrichs, Wouter L. J., Olinga, Peter, Melgert, Barbro N.
Publikováno v:
Lung; Jun2024, Vol. 202 Issue 3, p331-342, 12p
Autor:
Adhyatmika Adhyatmika, Leonie Beljaars, Kurnia S. S. Putri, Habibie Habibie, Carian E. Boorsma, Catharina Reker-Smit, Theerut Luangmonkong, Burak Guney, Axel Haak, Keri A. Mangnus, Eduard Post, Klaas Poelstra, Kim Ravnskjaer, Peter Olinga, Barbro N. Melgert
Publikováno v:
Pharmaceutics, Vol 12, Iss 5, p 471 (2020)
Osteoprotegerin (OPG) serum levels are associated with liver fibrogenesis and have been proposed as a biomarker for diagnosis. However, the source and role of OPG in liver fibrosis are unknown, as is the question of whether OPG expression responds to
Externí odkaz:
https://doaj.org/article/b319b910af32449c8e3333c092aedcec
Publikováno v:
Tropical Journal of Natural Product Research; Oct2022, Vol. 6 Issue 10, p1570-1575, 6p
Publikováno v:
Pharmacologytherapeutics. 228
Fibrosis is defined by excessive formation and accumulation of extracellular matrix proteins, produced by myofibroblasts, that supersedes normal wound healing responses to injury and results in progressive architectural remodelling. Fibrosis is often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bae10fb46d6ff572f30c5edc42ca8d4
https://pubmed.ncbi.nlm.nih.gov/34171336
https://pubmed.ncbi.nlm.nih.gov/34171336
Autor:
Peter Olinga, Catharina Reker-Smit, Barbro N. Melgert, Kurnia Sari Setio Putri, Leonie Beljaars, Emilia Gore, Adhyatmika Adhyatmika, Keri A. Mangnus, Detlef Schuppan
1.AbstractBackgroundsOsteoprotegerin (OPG) is a profibrotic mediator produced by myofibroblasts under influence of transforming growth factor β (TGFβ). Its expression in experimental models of liver fibrosis correlates well with disease severity an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a6d39cba2b93578aabe15ab928bbe6e
https://doi.org/10.1101/2020.12.11.421479
https://doi.org/10.1101/2020.12.11.421479
Publikováno v:
Majalah Farmaseutik; Vol 13, No 2 (2017)
Pentagamavunon-0 (disingkat PGV-0), suatu senyawa turunan kurkumin dengan rumus molekul 2,5-bis(4’-hidroksi-3’-metoksibenzilidin) siklopentanon, telah terbukti memiliki aktivitas anti inflamasi tanpa menimbulkan efek ulcerogenik. Namun, pada peng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc9cb70de20f5c538c51e3571c30024
https://journal.ugm.ac.id/majalahfarmaseutik/article/view/40916
https://journal.ugm.ac.id/majalahfarmaseutik/article/view/40916
Autor:
Henricus A. M. Mutsaers, Chuthamanee Suthisisang, Adhyatmika Adhyatmika, Theerut Luangmonkong, Koert P. de Jong, S. Suriguga, Dorenda Oosterhuis, Peter Olinga, Amirah Adlia
Publikováno v:
Luangmonkong, T, Suriguga, S, Adhyatmika, A, Adlia, A, Oosterhuis, D, Suthisisang, C, de Jong, K P, Mutsaers, H A M & Olinga, P 2018, ' In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β ', Toxicology and Applied Pharmacology, vol. 355, pp. 127-137 . https://doi.org/10.1016/j.taap.2018.07.001
Toxicology and Applied Pharmacology, 355, 127-137. ACADEMIC PRESS INC ELSEVIER SCIENCE
Toxicology and Applied Pharmacology, 355, 127-137. ACADEMIC PRESS INC ELSEVIER SCIENCE
Fibrosis is a pathophysiological state characterized by the excessive formation/deposition of fibrous extracellular matrix. Transforming growth factor-beta (TGF-β) is a central profibrotic mediator, and targeting TGF-β is a promising strategy in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0487c2cdf49aab824069d745b6d25fac
https://pure.au.dk/portal/da/publications/in-vitro-and-ex-vivo-antifibrotic-effects-of-ly2109761-a-small-molecule-inhibitor-against-tgf(aee10aec-f838-40cd-804c-9787fa1daead).html
https://pure.au.dk/portal/da/publications/in-vitro-and-ex-vivo-antifibrotic-effects-of-ly2109761-a-small-molecule-inhibitor-against-tgf(aee10aec-f838-40cd-804c-9787fa1daead).html
Autor:
Carian E. Boorsma, Eduard Post, Axel Haak, Kurnia Sari Setio Putri, Burak Guney, Klaas Poelstra, Catharina Reker-Smit, Barbro N. Melgert, Adhyatmika Adhyatmika, Leonie Beljaars
Publikováno v:
Journal of Hepatology. 66:S147-S148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7abd30ebe838ccc88a4244e6607ac5b7
https://doi.org/10.1016/s0168-8278(17)30566-4
https://doi.org/10.1016/s0168-8278(17)30566-4
Autor:
Eduard Post, Kurnia Sari Setio Putri, Peter Olinga, Leonie Beljaars, Emilia Gore, Catharina Reker-Smit, Barbro N. Melgert, Adhyatmika Adhyatmika, Klaas Poelstra, Keri A. Mangnus
Publikováno v:
Journal of Hepatology. 66:S147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7e1fffce821f590959dd35e3e21c9b2
https://doi.org/10.1016/s0168-8278(17)30565-2
https://doi.org/10.1016/s0168-8278(17)30565-2